Navigation Links
ICON Central Laboratories in Singapore Moves to New Facility to Meet Growing Demand
Date:6/26/2009

DUBLIN, June 26 /PRNewswire-FirstCall/ --

- Singapore Laboratory Testing Increases by 149% in Past Six Months

ICON plc (NASDAQ:ICLR: ISIN: IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has moved its Singapore central laboratory to a new, larger facility located at Loyang Way, Eastern Singapore. The new laboratory meets the growth in demand for ICON Central Laboratories' services in Singapore, which has increased by 149% over the past six months. The larger facility also enables ICON Central Laboratories to expand its test menu offerings in the region to include increased esoteric testing as well as flow cytometry, molecular diagnostics and biomarkers, to complement the services of ICON's other wholly-owned central laboratories in Europe, India and the United States.

"As ICON celebrates its tenth year of operation in Singapore, our move to a larger laboratory signals our continued commitment to the region," commented Bob Scott-Edwards, President, ICON Central Laboratories. "Singapore has become a regional hub for drug development in Asia-Pacific and we now have the capacity, the range of testing services and, above all, a highly experienced team of lab professionals to support the growth of clinical trials in the region."

ICON Central Laboratories Singapore supports all major therapeutic areas, including cardiovascular, oncology, endocrinology and metabolism, and virology. The laboratory serves as a regional hub for test samples from Australia, New Zealand, South Korea, Malaysia, Singapore, Taiwan, Japan, Thailand, Hong Kong, China and Indonesia. ICON Central Laboratories Singapore received CAP (College of American Pathologists) accreditation in March 2009, ensuring the highest standards of excellence in laboratory services.

About ICON Central Laboratori
'/>"/>

SOURCE ICON plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Medical Simulation Corporation to Introduce Central Line Management Program at the National Teaching Institute and Critical Care Exposition
2. GenVault Corporation Launches its Latest Centralized and Standardized Software Solution for Biobanking and Biological Sample Management, GenConnect 3.2
3. ACM Global Central Lab Announces Partnership with Chindexs United Family Hospitals in China
4. Bio-Tech Medical Software, Inc. Biometrics Joins Forces with the University of Central Florida to Fight Diversion and Help Combat Prescription Narcotic Drug Abuse
5. Health Robotics Expands i.v.STATION(TM) Partnership With Can-Med in 10 Countries Within Central Asia
6. Pioneering Cancer Center Introduces Advanced Varian RapidArc(TM) Treatments for Cancer Patients in Central Germany
7. ICON Opens Full Service Central Laboratory in India
8. Top Biopharma Company Adopts BioFortis Translational Research Software for Centralized Management and Mining of Clinical Biomarker Data
9. PAREXEL Enhances Early Phase Clinical Development Offering for Central Nervous System Studies
10. Sagent Pharmaceuticals Provides US$20,000 in Aid to Earthquake-Devastated Areas in Central China
11. Angiotechs novel 5-FU Central Venous Catheter receives FDA 510(k) clearance

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...-Stallergeneshasbeen,grantedEuropeanapprovaltomark...RecognitionProcedure.Germany,thefirstcountrywhere,...te. , Oralair(R)isnowregisteredinAustria,Belg...ce,Germany,Greece,Hungary,Ireland,Italy,Latvia,Li...tugal,Romania,Slovakia,Slovenia,andSpain.Alltheco...
(Date:11/25/2009)...t Economic Club of Canada , ...bassador to Speak at Economic Club of Canada., , ,...rnational Investment, and Chairman and CEO of the ...vid Appia go to www.investinfrance.org . , , ,Wh...ess to discuss recent pro-business initiatives ado...
(Date:11/25/2009)...ArdeaBiosciences,Inc.(Nasdaq: RDEA )announcedtoday...veofficer,willpresentatthePiperJaffray21stAnnualHe...llows:,PiperJaffray21stAnnualHealthCareConference...ime,Location:TheNewYorkPalaceHotel,NewYork,NY,Webc...rget=,_blank,title=,http://www.corporate-ir.net/ir...
(Date:11/24/2009)...omoreprestigiousuniversitieshavejoinedBioCareerCen...forlifescienceprofessionals. ,, Northwesternand...ng28othermajorlifesciencetrainingInstitutions. ,...post-graduatesinthelifesciences.Whiletherearehundr...Centeristheonlyonethatserveslifesciencepost-gradua...
Breaking Biology Technology:STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3French Ambassador for International Investment to Visit Toronto December 11 2Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2
...LLC of,Los Gatos, California today announced that ...d and Drug Administration (FDA) for its Workstatio...e is intended for softcopy reading,and interpretat...ed with,the goal of assisting radiologists to read...incorporates expert viewing methodology, including...
...in Board: AVTI) today announced financial results ...07., For the year ended September 30, 2007, Avita...operations compared to $4,519,000 from,continuing ...The operating,loss from continuing operations amou... was $2,260,000, or $0.09 per basic and diluted sh...
...icals, Inc. (Nasdaq: MLNM ) today announced that ...iotech Products, L.P. for achieving a,material sal...Milestone,payments are recorded in the strategic a...ment., (Logo: http://www.newscom.com/cgi-bin/prn...ader in the relapsed multiple myeloma setting,with...
Other Biology Technology:Avitar Reports Fourth Quarter and Fiscal Year 2007 Financial Results 2Avitar Reports Fourth Quarter and Fiscal Year 2007 Financial Results 3Avitar Reports Fourth Quarter and Fiscal Year 2007 Financial Results 4Millennium to Receive $40 Million Milestone Payment for Achievement of Sales Threshold for Velcade(R) (Bortezomib) for Injection 2Millennium to Receive $40 Million Milestone Payment for Achievement of Sales Threshold for Velcade(R) (Bortezomib) for Injection 3Millennium to Receive $40 Million Milestone Payment for Achievement of Sales Threshold for Velcade(R) (Bortezomib) for Injection 4Millennium to Receive $40 Million Milestone Payment for Achievement of Sales Threshold for Velcade(R) (Bortezomib) for Injection 5
(Date:11/25/2009)...ria don,t have easy lives. In addition to mammalia...natural enemies called bacteriophages, viruses tha... , Still, bacteria and another class of microorg... environments such as deep-sea volcanic vents) man...e a built-in defense system that helps protect the...
(Date:11/25/2009)...versity assistant professors recently received fun... continue research beneficial to understanding the... Christopher Blackwood, assistant professor in the...ants to support two separate research projects. ,...omposer Communities and Functions from the Leaf to...
(Date:11/24/2009)...ystallised a protein that may help gut bacteria bi...d be used by probiotic producers to identify strai.... , "Probiotics need to interact with cells linin... attach to surfaces in the gut they are more likel...ity," says Dr Nathalie Juge from the Institute of ...
Breaking Biology News(10 mins):Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Kent State University professors focus research on the environment with grants totaling $890,000 2A sticky solution for identifying effective probiotics 2In Colorado Commercial Medical and Pharmacy Benefit Enrollment Down at State Level 51883 1In Colorado Commercial Medical and Pharmacy Benefit Enrollment Down at State Level 51883 2Biostar Pharmaceuticals Inc Receives Government Approvals for Three New Products 51881 1Biostar Pharmaceuticals Inc Receives Government Approvals for Three New Products 51881 2Biostar Pharmaceuticals Inc Receives Government Approvals for Three New Products 51881 3Biostar Pharmaceuticals Inc Receives Government Approvals for Three New Products 51881 4A New Government Run Plan Would Impose Significant Financial Losses on California Hospitals 51879 1A New Government Run Plan Would Impose Significant Financial Losses on California Hospitals 51879 2A New Government Run Plan Would Impose Significant Financial Losses on California Hospitals 51879 3A New Government Run Plan Would Impose Significant Financial Losses on California Hospitals 51879 4
...he word "doctor" to mean "all-knowing," unfortunat...y on the part of medical professionals sometimes l...n additional suffering, or even death, for their p...rate medical diagnoses through the development of ... researcher is putting her engineering knowledge t...
...the greenhouse effect, some scientists have propos...is emitted from power plants, then liquefying the ... pitfalls in that plan. , The carbon dioxide can ... vent to the atmosphere, defeating the purpose of ...to-gas conversion happens suddenly, the gas can bu...
... is small in Australia and people can still safely... medicine specialist Dr Bob Doneley. , "The chanc...hbours birds are so infinitesimally small," UQ Sch...eley said. , "You,re more likely to have a light...somebody getting bird flu off their cockatiel." ,...
Other Biology News:Making medicine 'smarter' 2Asleep in the deep: Model helps assess ocean-injection strategy for combating greenhouse effect 2Expert dispels bird flu paranoia 2
...s are membrane-filtered isotonic and enzyme-free a...cell-conditioning agents in either Ca2+- and Mg2+-...g2+-free phosphate-buffered saline for gentle diss...s and each other for studies requiring intact cell...
... Blocking Reagent , 2 x 50 ml 10X TBST Wash Buf...glycerol stock , 0.2 ml BLT5403 glycerol stock ...7Select Positive Control Lysate , 1010 pfu T7Se...RP Conjugate , 2 ml T7Select S-protein , 50 ...
...ction Kits are designed for ultra-sensitive detect...ulose or PVDF membranes. Since all necessary reage...ibodies), the WesternBreeze Kits save you time in ...al results. Solutions are pre-mixed and optimized ...
Mouse Anti-L1 Cell Adhesion Molecule Monoclonal Antibody, Unconjugated, Clone UJ127 from GeneTex
Biology Products: